Eva Táborská

1.7k total citations
82 papers, 1.4k citations indexed

About

Eva Táborská is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Eva Táborská has authored 82 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pharmacology, 27 papers in Molecular Biology and 27 papers in Pharmacology. Recurrent topics in Eva Táborská's work include Berberine and alkaloids research (41 papers), Alkaloids: synthesis and pharmacology (17 papers) and Plant-based Medicinal Research (17 papers). Eva Táborská is often cited by papers focused on Berberine and alkaloids research (41 papers), Alkaloids: synthesis and pharmacology (17 papers) and Plant-based Medicinal Research (17 papers). Eva Táborská collaborates with scholars based in Czechia, Spain and Belgium. Eva Táborská's co-authors include Iva Slaninová, Hana Bochořáková, Jiřı́ Slanina, Jana Urbanová, Jiří Slavík, Stjepan Uldrijan, Jiřı́ Dostál, F. Kornalík, Otakar Humpa and Karl H. Schram and has published in prestigious journals such as Physical Chemistry Chemical Physics, Molecules and Phytochemistry.

In The Last Decade

Eva Táborská

81 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Táborská Czechia 22 687 555 274 268 262 82 1.4k
Satoshi Takamatsu Japan 27 689 1.0× 1.2k 2.2× 213 0.8× 428 1.6× 716 2.7× 90 2.4k
Shunyan Mo United States 19 470 0.7× 545 1.0× 128 0.5× 156 0.6× 362 1.4× 27 1.5k
D. Chuck Dunbar United States 18 350 0.5× 444 0.8× 164 0.6× 220 0.8× 419 1.6× 31 1.4k
Shinji Funayama Japan 24 477 0.7× 802 1.4× 160 0.6× 289 1.1× 522 2.0× 88 1.6k
Shih‐Chang Chien Taiwan 23 388 0.6× 723 1.3× 208 0.8× 433 1.6× 255 1.0× 62 1.5k
Masahiro Nagai Japan 24 216 0.3× 1.2k 2.1× 199 0.7× 266 1.0× 205 0.8× 59 1.7k
Sonja Sturm Austria 27 273 0.4× 849 1.5× 263 1.0× 467 1.7× 141 0.5× 79 1.8k
Eugene P. Mazzola United States 24 352 0.5× 604 1.1× 130 0.5× 663 2.5× 305 1.2× 85 1.7k
Shinichi Uesato Japan 23 266 0.4× 924 1.7× 180 0.7× 409 1.5× 270 1.0× 94 1.7k
Zhili Zuo China 25 460 0.7× 796 1.4× 252 0.9× 271 1.0× 378 1.4× 101 1.8k

Countries citing papers authored by Eva Táborská

Since Specialization
Citations

This map shows the geographic impact of Eva Táborská's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Táborská with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Táborská more than expected).

Fields of papers citing papers by Eva Táborská

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Táborská. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Táborská. The network helps show where Eva Táborská may publish in the future.

Co-authorship network of co-authors of Eva Táborská

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Táborská. A scholar is included among the top collaborators of Eva Táborská based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Táborská. Eva Táborská is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hošek, Jan, et al.. (2017). The capability of minor quaternary benzophenanthridine alkaloids to inhibit TNF-α secretion and cyclooxygenase activity. Acta Veterinaria Brno. 86(3). 223–230. 6 indexed citations
2.
Slanina, Jiřı́, et al.. (2017). Sanguinarine is reduced by NADH through a covalent adduct. Phytochemistry. 145. 77–84. 15 indexed citations
3.
Dovrtělová, Gabriela, et al.. (2016). Identification of metabolites of selected benzophenanthridine alkaloids and their toxicity evaluation. Journal of Pharmaceutical and Biomedical Analysis. 121. 174–180. 12 indexed citations
4.
Jarkovský, Jiří, et al.. (2013). Hydroxyl radicals’ production and ECG parameters during ischemia and reperfusion in rat, guinea pig and rabbit isolated heart. General Physiology and Biophysics. 32(2). 221–228. 3 indexed citations
5.
Slaninová, Iva, et al.. (2012). Alkaloid chelirubine and DNA: Blue and red luminescence. Talanta. 105. 317–319. 8 indexed citations
6.
Pěnčíková, Kateřina, et al.. (2012). Investigation of sanguinarine and chelerythrine effects on LPS-induced inflammatory gene expression in THP-1 cell line. Phytomedicine. 19(10). 890–895. 43 indexed citations
7.
Uldrijan, Stjepan, et al.. (2011). Benzo[c]phenanthridine alkaloids exhibit strong anti-proliferative activity in malignant melanoma cells regardless of their p53 status. Journal of Dermatological Science. 62(1). 22–35. 59 indexed citations
8.
Táborská, Eva, et al.. (2010). Effect of quaternary benzo[c]phenanthridine alkaloids sanguilutine and chelilutine on normal and cancer cells. Toxicology in Vitro. 24(3). 697–706. 44 indexed citations
9.
Urbanová, Jana, Přemysl Lubal, Iva Slaninová, Eva Táborská, & Petr Táborský. (2009). Fluorescence properties of selected benzo[c]phenantridine alkaloids and studies of their interaction with CT DNA. Analytical and Bioanalytical Chemistry. 394(4). 997–1002. 42 indexed citations
10.
Slaninová, Iva, Jiřı́ Slanina, & Eva Táborská. (2008). Fluorescence Properties of Quaternary Benzo[c]phenanthridine alkaloids and Their Use as Supravital DNA Probes. Chemické listy. 102(6). 2 indexed citations
11.
Slaninová, Iva, Jiřı́ Slanina, & Eva Táborská. (2007). Quaternary benzo[c]phenanthridine alkaloids—novel cell permeant and red fluorescing DNA probes. Cytometry Part A. 71A(9). 700–708. 37 indexed citations
12.
Bochořáková, Hana, et al.. (2007). HPLC quantification of seven quaternary benzo[c]phenanthridine alkaloids in six species of the family Papaveraceae. Journal of Pharmaceutical and Biomedical Analysis. 44(1). 283–287. 67 indexed citations
13.
Slanina, Jiřı́ & Eva Táborská. (2004). Příjem, biologická dostupnost a metabolismus rostlinnýchpolyfenolů u člověka. Chemické listy. 98(5). 239–245. 5 indexed citations
14.
Bochořáková, Hana, et al.. (2004). In vitro Methods for Estimation of the Antioxidant Activity of Natural Compounds. Chemické listy. 98(4). 8 indexed citations
15.
Slanina, Jiřı́ & Eva Táborská. (2004). Intake, Bioavailability, and Metabolisms of Plant Polyphenols in Humans. Chemické listy. 98(5). 1 indexed citations
16.
Bochořáková, Hana, et al.. (2003). Main flavonoids in the root of Scutellaria baicalensis cultivated in Europe and their comparative antiradical properties. Phytotherapy Research. 17(6). 640–644. 101 indexed citations
17.
Slaninová, Iva, Eva Táborská, Hana Bochořáková, & Jiřı́ Slanina. (2001). Interaction of benzo[c]phenanthridine and protoberberine alkaloids with animal and yeast cells. Cell Biology and Toxicology. 17(1). 51–63. 87 indexed citations
18.
Táborská, Eva, et al.. (1994). Separation of Alkaloids inChelidonium majusby Reversed Phase HPLC. Planta Medica. 60(4). 380–381. 25 indexed citations
19.
Táborská, Eva, et al.. (1992). Preparative Column Chromatography of Quaternary Benzophenanthridine Alkaloids of Dicranostigma lactucoides. Fitoterapia. 63(1). 10 indexed citations
20.
Táborská, Eva, et al.. (1987). Isolation ofN2-Methyl-1, 2, 3, 4-tetrahydro-β-carboline fromPapaver pavoninum. Planta Medica. 53(2). 232–232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026